Sfoglia per Autore
THE INTERPLAY BETWEEN CDK1/CLBS AND PP2A/CDC55 IN ADAPTATION TO THE SPINDLE ASSEMBLY CHECKPOINT (SAC)
2014 C. Vernieri
How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies
2016 S. Pusceddu, F. De Braud, G. Lo Russo, L. Concas, D. Femia, C. Vernieri, A. Indini, B. Formisano, R. Buzzoni
Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes
2016 S. Pusceddu, R. Buzzoni, C. Vernieri, L. Concas, S. Marceglia, L. Giacomelli, M. Milione, L. Leuzzi, D. Femia, B. Formisano, V. Mazzaferro, F. De Braud
Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up
2016 C. Vernieri, D. Femia, S. Pusceddu, C. Capella, J. Rosai, G. Calareso, L. Concas, N. Prinzi, G. Lo Russo, F. De Braud, R. Buzzoni
Update on medical treatment of small intestinal neuroendocrine tumors
2016 S. Pusceddu, D. Femia, G. Lo Russo, S. Ortolani, M. Milione, M. Maccauro, C. Vernieri, N. Prinzi, L. Concas, L. Leuzzi, F. De Braud, R. Buzzoni
Targeting cancer metabolism : Dietary and pharmacologic interventions
2016 C. Vernieri, S. Casola, M. Foiani, F. Pietrantonio, F. de Braud, V. Longo
Heterogeneity of acquired resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer
2017 F. Pietrantonio, C. Vernieri, G. Siravegna, A. Mennitto, R. Berenato, F. Perrone, A. Gloghini, E. Tamborini, S. Lonardi, F. Morano, B. Picciani, A. Busico, C.C. Volpi, A. Martinetti, F. Battaglin, I. Bossi, A. Pellegrinelli, M. Milione, C. Cremolini, M. Di Bartolomeo, A. Bardelli, F. De Braud
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer
2017 D. Oddo, G. Siravegna, A. Gloghini, C. Vernieri, B. Mussolin, F. Morano, G. Crisafulli, R. Berenato, G. Corti, C.C. Volpi, M. Buscarino, M. Niger, P.D. Dunne, G. Rospo, E. Valtorta, A. Bartolini, G. Fucà, S. Lamba, A. Martinetti, M. Di Bartolomeo, F. De Braud, A. Bardelli, F. Pietrantonio, F. Di Nicolantonio
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors
2017 S. Pusceddu, N. Prinzi, G. Lo Russo, D. Femia, M. Milione, F. Perrone, E. Tamborini, L. Concas, I. Pulice, C. Vernieri, F. Corti, R. Buzzoni, F. De Braud
Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study
2017 C. Vernieri, M. Milano, A. Mennitto, C. Maggi, B. Ferrari, L. Rinaldi, R. Mennitto, C. Stefanetti, B. Re, G. Mariani, G. Bianchi, G. Capri, F. de Braud
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
2018 S. Pusceddu, C. Vernieri, M. Di Maio, R. Marconcin, F. Spada, S. Massironi, T. Ibrahim, M. Brizzi, D. Campana, A. Faggiano, D. Giuffrida, M. Rinzivillo, S. Cingarlini, F. Aroldi, L. Antonuzzo, R. Berardi, L. Catena, C. De Divitiis, P. Ermacora, V. Perfetti, A. Fontana, P. Razzore, C. Carnaghi, V. Maria, C. Cauchi, M. Duro, S. Sergio, N. Fazio, F. Cavalcoli, A. Bongiovanni, A. La Salvia, N. Brighi, A. Colao, I. Puliafito, F. Panzuto, S. Ortolani, A. Zaniboni, F. Di Costanzo, M. Torniai, E. Bajetta, S. Tafuto, S. Garattini, D. Femia, N. Prinzi, L. Concas, G. Lo Russo, M. Milione, L. Giacomelli, R. Buzzoni, G. Delle Fave, V. Mazzaferro, F. de Braud
Cells Escape an Operational Mitotic Checkpoint through a Stochastic Process
2018 P. Bonaiuti, E. Chiroli, F. Gross, A. Corno, C. Vernieri, M. Štefl, M. Cosentino Lagomarsino, M. Knop, A. Ciliberto
Diet and supplements in cancer prevention and treatment : clinical evidences and future perspectives
2018 C. Vernieri, F. Nichetti, A. Raimondi, S. Pusceddu, M. Platania, F. Berrino, F. de Braud
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer
2018 C. Vernieri, A. Mennitto, M. Prisciandaro, V. Huber, M. Milano, L. Rinaldi, M. Cona, C. Maggi, B. Ferrari, S. Manoukian, G. Mariani, G. Bianchi, G. Capri, L. Rivoltini, F. de Braud
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC
2018 M. Moro, E. Caiola, M. Ganzinelli, E. Zulato, E. Rulli, M. Marabese, G. Centonze, A. Busico, U. Pastorino, F. de Braud, C. Vernieri, M. Simbolo, E. Bria, A. Scarpa, S. Indraccolo, M. Broggini, G. Sozzi, M. Garassino
Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting
2018 F. De Santis, M. Del Vecchio, L. Castagnoli, F. De Braud, S. Di Cosimo, D. Franceschini, G. Fucà, J. Hiscott, K.J. Malmberg, N. Mcgranahan, F. Pietrantonio, L. Rivoltini, S. Sangaletti, E. Tagliabue, C. Tripodo, C. Vernieri, L. Zitvogel, S.M. Pupa, M. Di Nicola
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma : the FAME Trial
2019 C. Vernieri, D. Signorelli, G. Galli, M. Ganzinelli, M. Moro, A. Fabbri, E. Tamborini, M. Marabese, E. Caiola, M. Broggini, L. Hollander, R. Gallucci, G. Vandoni, C. Gavazzi, T. Triulzi, M.P. Colombo, A.M. Rizzo, P.A. Corsetto, G. Pruneri, F. de Braud, G. Sozzi, V. Torri, M.C. Garassino
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
2019 G. Fucà, G. Galli, M. Poggi, G. Lo Russo, C. Proto, M. Imbimbo, R. Ferrara, N. Zilembo, M. Ganzinelli, A. Sica, V. Torri, M. Colombo, C. Vernieri, A. Balsari, F. de Braud, M. Garassino, D. Signorelli
Combination of baseline LDH, performance status and age as integrated algorithm to identify solid tumor patients with higher probability of response to anti PD-1 and PD-l1 monoclonal antibodies
2019 M.S. Cona, M. Lecchi, S. Cresta, S. Damian, M. Del Vecchio, A. Necchi, M.M. Poggi, D. Raggi, G. Randon, R. Ratta, D. Signorelli, C. Vernieri, F. de Braud, P. Verderio, M. Di Nicola
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer : a Retrospective Comparison of Efficacy and Safety Profiles
2019 C. Vernieri, M. Prisciandaro, M. Milano, M.S. Cona, C. Maggi, M. Brambilla, A. Mennitto, C. Fabbroni, E. Farè, S. Cresta, L. Celio, G. Mariani, G. Bianchi, G. Capri, F. de Braud
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile